Bactiguard Holding AB (publ)
Bactiguard Holding AB (publ) (0QV2.L) Financial Performance & Income Statement Overview
Explore the financials of Bactiguard Holding AB (publ) (0QV2.L), including yearly and quarterly data on income, cash flow, and balance sheets.
Bactiguard Holding AB (publ) (0QV2.L) Income Statement & Financial Overview
Review Bactiguard Holding AB (publ) 0QV2.L income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $59.05M | $68.26M | $73.94M | $57.35M |
Cost of Revenue | $10.97M | $5.46M | $7.20M | $70.40M |
Gross Profit | $48.08M | $62.80M | $66.74M | -$13.05M |
Gross Profit Ratio | $0.81 | $0.92 | $0.90 | -$0.23 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $6.30M |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $46.48M |
Operating Expenses | $50.70M | $66.001M | $68.68M | $59.88M |
Total Costs & Expenses | $61.66M | $71.46M | $75.88M | $70.40M |
Interest Income | $16000.00 | $4.11M | $0.00 | $0.00 |
Interest Expense | $4.88M | $3.26M | $4.19M | $5.04M |
Depreciation & Amortization | $12.02M | $8.10M | $19.03M | $12.06M |
EBITDA | $9.43M | $12.54M | $17.09M | -$989000.00 |
EBITDA Ratio | $0.16 | $0.18 | $0.23 | -$0.02 |
Operating Income | -$2.61M | -$3.20M | -$1.94M | -$13.05M |
Operating Income Ratio | -$0.04 | -$0.05 | -$0.03 | -$0.23 |
Other Income/Expenses (Net) | -$4.87M | $844000.00 | -$4.19M | -$5.04M |
Income Before Tax | -$7.48M | -$2.36M | -$6.13M | -$15.89M |
Income Before Tax Ratio | -$0.13 | -$0.03 | -$0.08 | -$0.28 |
Income Tax Expense | -$2.75M | -$1.44M | -$1.46M | -$1.57M |
Net Income | -$4.73M | -$920000.00 | -$4.67M | -$14.32M |
Net Income Ratio | -$0.08 | -$0.01 | -$0.06 | -$0.25 |
EPS | -$0.13 | -$0.03 | -$0.13 | -$0.41 |
Diluted EPS | -$0.13 | -$0.03 | -$0.13 | -$0.41 |
Weighted Avg Shares Outstanding | $35.04M | $35.04M | $35.04M | $35.04M |
Weighted Avg Shares Outstanding (Diluted) | $35.04M | $35.04M | $35.04M | $35.04M |
Over the last four quarters, Bactiguard Holding AB (publ)'s revenue moved from $57.35M in Q2 2024 to $59.05M in Q1 2025. Operating income in Q1 2025 was -$2.61M, with a strong operating margin of -4%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bactiguard Holding AB (publ) remained robust at $9.43M, reflecting operational efficiency. Net income dropped to -$4.73M, with an EPS of -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan